# Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Type 2 Diabetes Mellitus

> **NCT01677013** · PHASE1,PHASE2 · COMPLETED · sponsor: **Peking University Aerospace Center Hospital** · enrollment: 1026 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **OTHER:** BMMCT

## Key facts

- **NCT ID:** NCT01677013
- **Lead sponsor:** Peking University Aerospace Center Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2015-05
- **Final completion:** 2017-07
- **Target enrollment:** 1026 (ACTUAL)
- **Last updated:** 2017-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01677013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01677013, "Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01677013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*